Voyageur Pharma reports 99.8% iodine purity in Mueller extraction process tests
Reuters2026/08/10 11:03- Voyageur Pharmaceuticals reported lab results for its patent-pending Mueller process, producing iodine at 99.8% purity with overall recovery above 90%.
- Houston lab work used Anadarko and Permian Basin produced water, demonstrating continuous operation with clean brine suitable for disposal or reinjection.
- A mobile pilot unit sized for 80,000 liters per day is built; field testing is set to start in coming weeks, with operations planned for September 2026.
- Preliminary design work outlined a 200 metric-ton-per-year modular plant concept, targeting multiple disposal sites with a central finishing hub.
- The program supports a planned North American iodine supply chain; long-term goal targets up to 1,000 metric tons per year of iodine capacity.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Malaysia consulting company V Capital Consulting Group (VCCG.US) IPO priced at $4 per share, plans to raise $30 millions
Malaysian business consulting firm V Capital Consulting Group announced its initial public offering (IPO) terms on Thursday.
Adelayde Exploration shares gain DTC eligibility for US electronic clearing and settlement
Jefferies Initiates Coverage on Nuclear Energy Stocks: Cameco (CCJ.US) and BWX Technologies (BWXT.US) Rated "Buy," Nuclear Energy Enters the Strongest Demand Cycle in Forty Years
AI data centers are driving up demand for nuclear power, and Jefferies is optimistic about Cameco and BWXT leading the nuclear energy supercycle.
Crypto prices
More
